Avidity Biosciences, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Avidity Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • Avidity Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $11.8M, a 111% increase year-over-year.
  • Avidity Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $32.7M, a 120% increase year-over-year.
  • Avidity Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $23.4M, a 375% increase from 2022.
  • Avidity Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $4.92M, a 11610% increase from 2021.
  • Avidity Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was $42K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $23.4M +$18.5M +375% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $4.92M +$4.88M +11610% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $42K +$120K Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$78K +$7.32M +98.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$7.4M -$6.68M -931% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$718K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.